Companies · Medical Devices
Europe · Medical Devices
Diligence memoA one-page analyst read on Intu Diagnostics — recommendation, valuation, rhythm, risks.→Intu Diagnostics looks fair against its niche peers and is active on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Intu Diagnostics is one of 233 Medical Devices companies tracked from Europe. By capital raised it ranks mid-pack (ahead of 45% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
<p>Intu Diagnostics, a Liepzig-based startup developing a platform for completely lab-free molecular diagnostics, has closed a €1.1 million strategic bridge round- bringing their total funding secured to over €3 million. The round was supported by BSV Ventures, SAB (Saxonian Development Bank) and bu
<p>Intu Diagnostics, a Liepzig-based startup developing a platform for completely lab-free molecular diagnostics, has closed a €1.1 million strategic bridge round- bringing their total funding secured to over €3 million. The round was supported by BSV Ventures, SAB (Saxonian Development Bank) and business angels. The proceeds will be used to further strengthen Intu Diagnostics’ intellectual […]</p> <p>The post <a href="https://www.eu-startups.com/2026/06/lab-free-testing-moves-closer-to-home-as-germanys-intu-diagnostics-raises-e1-1-million/">Lab-free testing moves closer to home as Germany’s Intu Diagnostics raises €1.1 million</a> appeared first on <a href="https://www.eu-startups.com">EU-Startups</a>.</p>
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 45% of sector peers (real $). Modeled value above 25% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #4 of 8.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Rose Diagnostics Inc. | Seed | $3.3M | $7.2M | 4.09× |
| Pace Surgical, Inc. | Seed | $4.9M | $3.4M | 1.95× |
| MemorialCare Surgical Center at Saddleback, LLC | Seed | $3.9M | $2.4M | 1.36× |
| Intu Diagnostics this company | Seed | $1.2M | $2.2M | 1.22× |
| Persperion Diagnostics Inc. | Seed | $4.4M | $1.4M | 0.78× |
| Origami Surgical Inc. | Seed | $6.8M | $1.3M | 0.72× |
| Danbury Surgical Center Lp | Seed | $6.2M | $690K | 0.39× |
| North Dallas Surgical Center, LLC | Seed | $2.9M | $339K | 0.19× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $1.2M | 2026-06-26 | $5.9M | $2.2M | 45% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Intu Diagnostics is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Nashville Midtown Surgical, LLC | Medical Devices | Seed | $1.2M | $35.5M | same sector · same stage |
| SafeGuard Surgical, Inc. | Medical Devices | Seed | $1.1M | $5.9M | same sector · same stage |
| Legacy Surgical Holding, LLC | Medical Devices | Seed | $1.0M | $30.7M | same sector · same stage |
| Aultman North Surgical Partners, LLC | Medical Devices | Seed | $1.5M | $8.2M | same sector · same stage |
| Fera Diagnostics & Biologicals Corp. | Medical Devices | Seed | $1.5M | $34.0M | same sector · same stage |
| ACES Diagnostics, Inc. | Medical Devices | Seed | $1.6M | $7.3M | same sector · same stage |
| Strauss Surgical USA LLC | Medical Devices | Seed | $1.6M | $7.9M | same sector · same stage |
| Centrus Diagnostics, Inc. | Medical Devices | Seed | $1.7M | $7.4M | same sector · same stage |
See where Intu Diagnostics sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Intu Diagnostics, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.